ArticleEvaluation & the health professions2026
The "Twilight Zone" Is a Danger Zone: Why the Occupational-Clinical Divide in Burnout Assessment Is a False Dichotomy.
Article in Evaluation & the health professions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
De Beer (2026) argues that burnout's ICD-11 classification as an "occupational phenomenon" necessitates a stricter separation between organizational screening and clinical diagnosis. This commentary challenges that "dual approach" as a false dichotomy that underestimates the biological reality of chronic stress. Drawing on biomarker research from 2024 and 2025 and the validation logic of the Burnout Assessment Tool that De Beer published on extensively in the past, I argue that the occupational-clinical split risks functioning as a liability shield rather than a care pathway. When we deny the diagnostic validity of workplace screening, we create a "Twilight Zone" where employees with severe symptoms can be given organizational "risk" labels without corresponding clinical recognition or care. I propose an Integrated Continuum Model where workplace screening functions as valid Stage 1 assessment within a coordinated care pathway, ensuring that high-risk scores trigger immediate clinical triage rather than administrative limbo. The failure to integrate these approaches does not protect employees. It leaves them without a clear path to appropriate care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.